“…Ozagrel, selective thromboxane A2 CI confidence interval, GCS Glasgow Coma Scale, T3 7 day after operation, QTc interval heart rate-corrected QT interval CI confidence interval, GCS Glasgow Coma Scale, T3 7 day after operation, QTc interval heart rate-corrected QT interval synthase inhibitor, ameliorates platelet aggregation, vascular constriction, and brain edema in acute cerebral ischemia [36]. Fasudil, rho-kinase inhibitor, improves hemodynamic function by increasing regional cerebral blood flow, preventing hyperviscosity, and upregulating endothelial nitric oxide synthase activity in endothelial cells [37]. These drugs do not have the cardiac side effects in clinical use.…”